Previous close | 49.54 |
Open | 49.25 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 48.30 - 49.44 |
52-week range | 42.63 - 57.82 |
Volume | |
Avg. volume | 1,855,604 |
Market cap | 124.089B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 20.86 |
EPS (TTM) | 2.33 |
Earnings date | N/A |
Forward dividend & yield | 2.04 (4.19%) |
Ex-dividend date | 09 May 2024 |
1y target est | 59.32 |
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In this article, we will be taking a look at the 32 countries with the highest rates of diabetes. If you do not want to learn about the global diabetes market, head straight to the 5 Countries with the Highest Rates of Diabetes. The Global Diabetes Market and Its Implications The global diabetes market is […]
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial […]